Evusheld

Evusheld is a combination of Cilgavimab and Tixagevimab, used for preventive treatment. This medication is administered intramuscularly and is manufactured by AstraZeneca AB in the EU.

Evushel is designed to help prevent COVID-19 in certain individuals. It is typically used for those who may not respond well to COVID-19 vaccines. This medication works by providing antibodies that can help the immune system fight off the virus.

Common effects of Evusheld may include reactions at the injection site, such as pain, swelling, or redness. Some individuals might also experience general side effects like fatigue, headache, or muscle pain. These effects are usually mild and temporary.

Evusheld should be used with caution in individuals with a history of severe allergic reactions to any of its components. It is important to inform your healthcare provider about any allergies or medical conditions before starting this treatment. Always follow the advice of a healthcare professional regarding the use of this medication.

Evusheld may interact with other medications, particularly those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, the effects of Evusheld on other treatments are not fully understood, so caution is advised.